425
Views
12
CrossRef citations to date
0
Altmetric
Original Investigation

Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy

, , , &
Pages 608-614 | Received 12 Nov 2014, Accepted 15 Jan 2015, Published online: 27 Mar 2015

References

  • Allen SJ, Dawbarn D. 2006. Clinical relevance of the neurotrophins and their receptors. Clin Sci 110:175–191.
  • Autry AE, Monteggia LM. 2012. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238–258.
  • Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. 2005. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate. J Neuroimmunol 167:215–218.
  • Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, et al. 2013. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst 105:1432–1440.
  • Cai Q, Sheng ZH. 2011. Uncovering the role of Snapin in regulating autophagy-lysosomal function. Autophagy 7:445–447.
  • Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. 2002. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24:547–561.
  • Chen A, Xiong LJ, Tong Y, Mao M. 2013. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed Rep 1:167–176.
  • Cheville AL, Basford JR, Troxel AB, Kornblith AB. 2009. Performance of common clinician- and self-report measures in assessing the function of community-dwelling people with metastatic breast cancer. Arch Phys Med Rehabil 90:2116–2124.
  • Coenen VA, Schlaepfer TE, Maedler B, Panksepp J. 2011. Cross-species affective functions of the medial forebrain bundle - Implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 35:1971–1981.
  • Croll SD, Ip NY, Lindsay RM, Wiegand SJ. 1998. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res 812:200–208.
  • Depperman S, Storchak H, Fallgatter AJ, Ehlis AS. 2014. Stress-induced neuroplasticity: maladaptation to adverse life events in patients with PTSD – a critical overview. Neuroscience 283:166–177.
  • Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127.
  • Fava M. 2003. Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psych 64(Suppl 14):30–34.
  • Ferguson M, Dennehy EB, Marangell LB, Martinez J, Wisniewski SR. 2014. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: Secondary analysis of STAR*D. Curr Med Res Opin 30:2109–2118.
  • Glaus A, Crow R, Hammond S. 1996. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care (Engl) 5(2 Suppl):8–23.
  • Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, et al. 2012. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry 17:1130–1142.
  • Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. 2007. Cancer-related fatigue: The scale of the problem. Oncologist 12(Suppl 1):4–10.
  • Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J. 2012. Cancer-related fatigue: Epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int 109:161–171.
  • Ilardi JM, Mochida S, Sheng ZH. 1999. Snapin: A SNARE-associated protein implicated in synaptic transmission. Nat Neurosci 2: 119–124.
  • Johnson MJ, Bland JM, Davidson PM, Newton PJ, Oxberry SG, Abernethy AP, Currow DC. 2014. The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale. J Pain Symptom Manage 47:652–658.
  • Kaplan DR, Miller FD. 2000. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381–391.
  • Kim DH, Zhao X. 2005. BDNF protects neurons following injury by modulation of caspase activity. Neurocrit Care 3:71–76.
  • Kuczewski N, Porcher C, Lessmann V, Medina I, Gaiarsa J-L. 2009. Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol 39:37–49.
  • Lakshminarasimhan H, Chattarji S. 2012. Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PLoS One 7:e30481.
  • Licinio J, Wong M. 2002. Brain-derived neurotrophic factor (BDNF) in stress and affective disorders. Mol Psychiatry 7:519.
  • Luhder F, Gold R, Flugel A, Linker RA. 2013. Brain-derived neurotrophic factor in neuroimmunology: Lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models. Arch Immunol Ther Exp (Warsz) 61:95–105.
  • Markham A, Cameron I, Bains R, Franklin P, Kiss JP, Schwendimann L, et al. 2012. Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways. Eur J Neurosci 35:366–374.
  • McAllister AK, Lo DC, Katz LC. 1995. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15:791–803.
  • Moberg PJ, Lazarus LW, Mesholam RI, Bilker W, Chuy IL, Neyman I, et al. 2001. Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 9:35–40.
  • Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S. 2002. Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398.
  • Norden DM, Bicer S, Clark Y, Jing R, Henry CJ, Wold LE, et al. 2014. Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function. Brain Behav Immun 43:76–85.
  • Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, et al. 2003. National Institutes of Health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue. J Natl Cancer Inst 95: 1110–1117.
  • Portenoy RK, Itri LM. 1999. Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 4:1–10.
  • Quintero IB, Herrala AM, Araujo CL, Pulkka AE, Hautaniemi S, Ovaska K, et al. 2013. Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma. PLos One, 8:e73072.
  • Saligan LN, Hsiao CP, Wang D, Wang XM, John LS, Kaushal A, et al. 2013. Upregulation of alpha-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain Behav Immun 27:63–70.
  • Sarhan M, Pawlowski SA, Barthas F, Yalcin I, Kaufling J, Dardente H, et al. 2013. BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia. Int J Neuropsychopharmacol 16:1649–1660.
  • Schuman EM 1999. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol, 9:105–109.
  • Scuri M, Samsell L, Piedimonte G. 2010. The role of neurotrophins in inflammation and allergy. Inflamm Allergy Drug Targets 9:173–180.
  • Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527–532.
  • Song HJ, Ming GL, Poo MM. 1997. cAMP-induced switching in turning direction of nerve growth cones. Nature 388: 275–279.
  • Suri D, Vaidya VA. 2013. Glucocorticoid regulation of brain-derived neurotrophic factor: Relevance to hippocampal structural and functional plasticity. Neuroscience 239:196–213.
  • Tokuyama W, Okuno H, Hashimoto T, Xin Li Y, Miyashita Y. 2000. BDNF upregulation during declarative memory formation in monkey inferior temporal cortex. Nat Neurosci 3: 1134–1142.
  • Tyler WJ, Perrett SP, Pozzo-Miller LD. 2002. The role of neurotrophins in neurotransmitter release. Neuroscientist 8:524–531.
  • Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. 2006. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res 1070:124–130.
  • Vega JA, Garcia-Suarez O, Hannestad J, Pérez-Pérez M, Germanà A. 2003. Neurotrophins and the immune system. J Anat 203: 1–19.
  • Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. 2005. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14:285–295.
  • Xiao N, Lin Y, Cao H, Sirjani D, Giaccia AJ, Koong CS, et al. 2014. Neurotrophic factor GDNF promotes survival of salivary stem cells. J Clin Invest 124:3364–3377.
  • Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. 1997. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.